088sek
-1,8 %
Date:2024-06-19Time:17:22:25Latest report:Q1-2024List:First NorthTicker:NANEXA
Market Cap:120 msekEnterprise Value:74 msekNet Sales:28,9 msekEarnings:-70,6 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:0,90
MA50:0,83
MA200:1,05
Price/MA200:-14,6 %
RSI (14):50,7
Price/MA50:8,2 %

Description

Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its products and also has collaboration agreements with several pharma companies, among others AstraZeneca. Geographically, the company derives maximum revenue from Nordic countries.

Medical Equipment